ArticleScientific reports2025
Diabetes duration, glycemic control, and risk of stroke and stroke subtypes: a nationwide prospective cohort study.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Sociodemographic predictors of glycaemic control among adults with type 2 diabetes mellitus in a Nigerian population: implications for public health and service delivery.BMC public health · 2026Article
- Association Between Insulin Regimen and Cardiovascular Risk in Indonesian Patients with Type 2 Diabetes Mellitus: A Cross-Sectional Study.Therapeutics and clinical risk management · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
To evaluate the relationship of diabetes duration and glycemic control with risk of stroke and its major subtypes using data from the UK Biobank, a large population-based cohort of UK adults. We included 23,401 UK adult residents with diabetes who had no known stroke at baseline (2006-2010). Diabetes duration was self-reported and glycemic control was assessed by glycated hemoglobin (HbA1c) levels. Their associations with incident stroke were assessed using multivariate Cox models. During a median follow-up of 11.6 years, 982 incident cases of stroke were identified. A longer diabetes duration was associated with higher risk of total stroke, ischemic stroke (IS), and hemorrhagic stroke (HS) (≥ 15 vs. <5 years: HRs [95% CI] were 1.81 [1.50, 2.19], 1.80 [1.47, 2.20], and 2.17 [1.46, 3.23], respectively), while higher levels of HbA1c were associated with higher risk of total stroke and IS but not HS (≥ 8.0% vs. <7.0%: HRs [95% CI] were 1.78 [1.52, 2.09], 1.93 [1.63, 2.28], and 0.97 [0.67, 1.41], respectively). Diabetes duration interacted with glycemic status on total stroke and IS (both P-for-interaction values < 0.01). Individuals who had the longest diabetes duration (≥ 15 years) and poorer glycemic control (≥ 8.0%) had particularly higher risk of total stroke (HR = 3.21; 95% CI: 2.55, 4.04) and IS (HR = 3.47; 95% CI: 2.73, 4.40) as compared with those who had a duration of < 5 years with HbA1c < 8%. A longer diabetes duration and poorer glycemic control were both associated with higher risk of total stroke and IS, and the risk may be further exacerbated with the coexistence of both risk factors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.